The global market for Hepatitis B Therapeutics was valued at US$ 2712 million in the year 2024 and is projected to reach a revised size of US$ 3326 million by 2031, growing at a CAGR of 3.0% during the forecast period.

Hepatitis B Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Hepatitis B Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Therapeutics.

The Hepatitis B Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis B Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis B Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hepatitis B Therapeutics Market Report

Report Metric	Details
Report Name	Hepatitis B Therapeutics Market
Accounted market size in year	US$ 2712 million
Forecasted market size in 2031	US$ 3326 million
CAGR	3.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hepatitis B Vaccine Anti-viral Drugs
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis B Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hepatitis B Therapeutics Market growing?

Ans: The Hepatitis B Therapeutics Market witnessing a CAGR of 3.0% during the forecast period 2025-2031.

What is the Hepatitis B Therapeutics Market size in 2031?

Ans: The Hepatitis B Therapeutics Market size in 2031 will be US$ 3326 million.

Who are the main players in the Hepatitis B Therapeutics Market report?

Ans: The main players in the Hepatitis B Therapeutics Market are GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis, Merck

What are the Application segmentation covered in the Hepatitis B Therapeutics Market report?

Ans: The Applications covered in the Hepatitis B Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Hepatitis B Therapeutics Market report?

Ans: The Types covered in the Hepatitis B Therapeutics Market report are Hepatitis B Vaccine, Anti-viral Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hepatitis B Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hepatitis B Vaccine

1.2.3 Anti-viral Drugs

1.3 Market by Application

1.3.1 Global Hepatitis B Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hepatitis B Therapeutics Market Perspective (2020-2031)

2.2 Global Hepatitis B Therapeutics Growth Trends by Region

2.2.1 Global Hepatitis B Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hepatitis B Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Hepatitis B Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Hepatitis B Therapeutics Market Dynamics

2.3.1 Hepatitis B Therapeutics Industry Trends

2.3.2 Hepatitis B Therapeutics Market Drivers

2.3.3 Hepatitis B Therapeutics Market Challenges

2.3.4 Hepatitis B Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hepatitis B Therapeutics Players by Revenue

3.1.1 Global Top Hepatitis B Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Hepatitis B Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hepatitis B Therapeutics Revenue

3.4 Global Hepatitis B Therapeutics Market Concentration Ratio

3.4.1 Global Hepatitis B Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutics Revenue in 2024

3.5 Global Key Players of Hepatitis B Therapeutics Head office and Area Served

3.6 Global Key Players of Hepatitis B Therapeutics, Product and Application

3.7 Global Key Players of Hepatitis B Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B Therapeutics Breakdown Data by Type

4.1 Global Hepatitis B Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Hepatitis B Therapeutics Forecasted Market Size by Type (2026-2031)

5 Hepatitis B Therapeutics Breakdown Data by Application

5.1 Global Hepatitis B Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Hepatitis B Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hepatitis B Therapeutics Market Size (2020-2031)

6.2 North America Hepatitis B Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hepatitis B Therapeutics Market Size by Country (2020-2025)

6.4 North America Hepatitis B Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hepatitis B Therapeutics Market Size (2020-2031)

7.2 Europe Hepatitis B Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hepatitis B Therapeutics Market Size by Country (2020-2025)

7.4 Europe Hepatitis B Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hepatitis B Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Hepatitis B Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hepatitis B Therapeutics Market Size (2020-2031)

9.2 Latin America Hepatitis B Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hepatitis B Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Hepatitis B Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hepatitis B Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Hepatitis B Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction

11.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction

11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Novira Therapeutics

11.3.1 Novira Therapeutics Company Details

11.3.2 Novira Therapeutics Business Overview

11.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction

11.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.3.5 Novira Therapeutics Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction

11.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Abivax

11.5.1 Abivax Company Details

11.5.2 Abivax Business Overview

11.5.3 Abivax Hepatitis B Therapeutics Introduction

11.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.5.5 Abivax Recent Development

11.6 F. Hoffmann- La Roche

11.6.1 F. Hoffmann- La Roche Company Details

11.6.2 F. Hoffmann- La Roche Business Overview

11.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction

11.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.6.5 F. Hoffmann- La Roche Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Hepatitis B Therapeutics Introduction

11.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Hepatitis B Therapeutics Introduction

11.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2020-2025)

11.8.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Hepatitis B Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hepatitis B Vaccine

Table 3. Key Players of Anti-viral Drugs

Table 4. Global Hepatitis B Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Hepatitis B Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Hepatitis B Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Hepatitis B Therapeutics Market Share by Region (2020-2025)

Table 8. Global Hepatitis B Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Hepatitis B Therapeutics Market Share by Region (2026-2031)

Table 10. Hepatitis B Therapeutics Market Trends

Table 11. Hepatitis B Therapeutics Market Drivers

Table 12. Hepatitis B Therapeutics Market Challenges

Table 13. Hepatitis B Therapeutics Market Restraints

Table 14. Global Hepatitis B Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Hepatitis B Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2024)

Table 17. Ranking of Global Top Hepatitis B Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Hepatitis B Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Hepatitis B Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Hepatitis B Therapeutics, Product and Application

Table 21. Global Key Players of Hepatitis B Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Hepatitis B Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Hepatitis B Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Hepatitis B Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Hepatitis B Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Hepatitis B Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Hepatitis B Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Hepatitis B Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Hepatitis B Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Hepatitis B Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Hepatitis B Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Hepatitis B Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Hepatitis B Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Hepatitis B Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Hepatitis B Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Hepatitis B Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Hepatitis B Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Hepatitis B Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Hepatitis B Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Hepatitis B Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. GlaxoSmithKline Company Details

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline Hepatitis B Therapeutics Product

Table 49. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. Bristol-Myers Squibb Company Details

Table 52. Bristol-Myers Squibb Business Overview

Table 53. Bristol-Myers Squibb Hepatitis B Therapeutics Product

Table 54. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Bristol-Myers Squibb Recent Development

Table 56. Novira Therapeutics Company Details

Table 57. Novira Therapeutics Business Overview

Table 58. Novira Therapeutics Hepatitis B Therapeutics Product

Table 59. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Novira Therapeutics Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Hepatitis B Therapeutics Product

Table 64. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Abivax Company Details

Table 67. Abivax Business Overview

Table 68. Abivax Hepatitis B Therapeutics Product

Table 69. Abivax Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Abivax Recent Development

Table 71. F. Hoffmann- La Roche Company Details

Table 72. F. Hoffmann- La Roche Business Overview

Table 73. F. Hoffmann- La Roche Hepatitis B Therapeutics Product

Table 74. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 75. F. Hoffmann- La Roche Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Hepatitis B Therapeutics Product

Table 79. Novartis Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. Merck Company Details

Table 82. Merck Business Overview

Table 83. Merck Hepatitis B Therapeutics Product

Table 84. Merck Revenue in Hepatitis B Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Merck Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Hepatitis B Therapeutics Picture

Figure 2. Global Hepatitis B Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hepatitis B Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Hepatitis B Vaccine Features

Figure 5. Anti-viral Drugs Features

Figure 6. Global Hepatitis B Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Hepatitis B Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Hepatitis B Therapeutics Report Years Considered

Figure 12. Global Hepatitis B Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Hepatitis B Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Hepatitis B Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Hepatitis B Therapeutics Market Share by Players in 2024

Figure 16. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2024

Figure 18. North America Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Hepatitis B Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Hepatitis B Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Hepatitis B Therapeutics Market Share by Region (2020-2031)

Figure 32. China Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Hepatitis B Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Hepatitis B Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Hepatitis B Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 49. Novira Therapeutics Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 51. Abivax Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 52. F. Hoffmann- La Roche Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 54. Merck Revenue Growth Rate in Hepatitis B Therapeutics Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Antiviral Drugs Market

Influenza Diagnostics Market

Anti Viral Coatings Market

Sterile and Antiviral Packaging Market

Specific Antiviral Drugs for COVID 19 Market

Novel Antiviral Drugs Market

Direct acting Antiviral Drugs Market

Influenza Antiviral Drugs Market

Antiviral Therapy Market

HIV Therapeutics Market

Protease Inhibitors Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions